Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern

In patients with atypical hemolytic uremic syndrome (aHUS), complement blocking by eculizumab rapidly halts the process of thrombotic microangiopathy and it is associated with clear long-term hematologic and renal improvements. Eculizumab treatment consists of a 4-week initial phase with weekly IV a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Nephrol
Main Authors: García Monteavaro, Camino, Peralta Roselló, Carmen, Quiroga, Borja, Baltar Martín, José María, Castillo Eraso, Lorena, de Álvaro Moreno, Fernando, Martínez Vea, Alberto, Visus-Fernández de Manzanos, María Teresa
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153492/
https://ncbi.nlm.nih.gov/pubmed/28025630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7471082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados